Non-radiographic axial spondyloarthritis localized to the thoracolumbar junction (T12–L1 region), confirmed by clinical criteria and MRI findings rather than plain radiographic sacroiliitis.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 6
- Region
- Spine
Documentation tips
What should appear in the chart to support M45.A5.
Source · Editorial brief grounded in 5 cited references ↓
- Document that plain radiographs do NOT show sacroiliitis meeting modified New York criteria — the absence of radiographic findings is what justifies nr-axSpA over ankylosing spondylitis.
- Record MRI findings explicitly: active bone marrow edema or structural lesions at the sacroiliac joints consistent with sacroiliitis, along with the spinal region(s) involved.
- Note HLA-B27 status, CRP/ESR values, and BASDAI score where available — payers reviewing biologic prior authorizations will look for this supporting data.
- Specify 'thoracolumbar region' (T12–L1 junction) by name in the assessment; vague documentation like 'mid-back and lower back pain' will not support M45.A5 over a nonspecific pain code.
- If the rheumatologist is managing the condition but the orthopedic provider is coding a related encounter, ensure the diagnosis is carried forward with the same specificity and supported by the shared record.
Related CPT procedures
Procedure codes commonly billed with M45.A5. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M45.A5 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M45.5 (ankylosing spondylitis of thoracolumbar region) when the patient has nr-axSpA — these are mutually exclusive; the distinction hinges on radiographic sacroiliitis, not symptom location.
- Defaulting to M45.A0 (unspecified sites) when the provider has documented thoracolumbar involvement — always code to the highest specificity the documentation supports.
- Reporting the non-billable parent code M45.A instead of the region-specific child code M45.A5 — claims submitted at the parent level will reject.
- Coding M46.8 for nr-axSpA after FY2022 — the dedicated M45.A subcategory replaced M46.8 as the appropriate home for nr-axSpA diagnoses.
- Failing to verify payer acceptance of M45.A5 — the code was new in FY2022 and some legacy payer systems may not have updated their tables; check remittance advice and re-submit with documentation if rejected.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M45.A5 applies when a provider has documented non-radiographic axial spondyloarthritis (nr-axSpA) with primary involvement at the thoracolumbar region. The defining feature of nr-axSpA is inflammatory spinal disease that meets clinical and MRI-based diagnostic criteria but lacks the radiographic sacroiliitis (grade ≥2 bilateral or grade ≥3 unilateral) required for ankylosing spondylitis under the modified New York criteria. If X-rays confirm structural sacroiliitis, use the ankylosing spondylitis family (M45.0–M45.9) instead.
The M45.A subcategory was introduced as a new code effective October 1, 2021, giving nr-axSpA its own distinct classification separate from the catch-all M46.8. M45.A5 is the thoracolumbar-specific billable code within that subcategory. If involvement spans multiple spinal regions, consider M45.AB (multiple sites). If the region is not specified in documentation, drop to M45.A0 (unspecified sites in spine) — but query the provider before defaulting to unspecified.
Excludes1 at the M45 parent level rules out arthropathy in Reiter's disease (M02.3–) and juvenile ankylosing spondylitis (M08.1). Excludes2 flags Behçet's disease (M35.2) as separately codable when present. Confirm the diagnosing provider is a rheumatologist or specialist who has documented the basis for nr-axSpA — payers increasingly scrutinize this code given its role in supporting biologic therapy authorization.
Sibling codes
Other billable codes under M45.A (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the difference between M45.A5 and M45.5?
02When did M45.A5 become a valid billable code?
03Can M45.A5 be used for an orthopedic encounter, or is it rheumatology-only?
04What if the patient has nr-axSpA affecting both the thoracolumbar and lumbar regions?
05Does M45.A5 support biologic therapy prior authorization?
06Is HLA-B27 positivity required to code M45.A5?
07What Excludes1 conditions must be ruled out before using M45.A5?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M45-M49/M45-/M45.A5
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M45.A5
- 04ucb-usa.comhttps://www.ucb-usa.com/sites/default/files/2023-11/nr-axspa-icd-10.pdf
- 05cms.govhttps://www.cms.gov/files/document/fy-2025-icd-10-cm-coding-guidelines.pdf
Mira AI Scribe
Mira AI Scribe captures the spinal region descriptor ('thoracolumbar'), the absence of radiographic sacroiliitis on plain films, MRI sacroiliitis findings, HLA-B27 result, and inflammatory marker values (CRP/ESR) from the encounter note. Capturing these elements prevents a downcode to M45.A0 (unspecified) or an erroneous crossover to M45.5 (ankylosing spondylitis), both of which can delay biologic prior authorization.
See how Mira captures M45.A5 documentation